Pfizer has gained FDA approval for Eucrisa, a new eczema treatment which could achieve peak annual sales of $2 billion a year. The drug is significant because it is the first non-steroidal therapy ...

At the age of four, Joel Godfrey's eczema was wreaking ... Joel's life has been transformed by a new ointment called tacrolimus which is based on an anti-rejection drug used in transplants.

Skin experts are to test a new cream for the treatment of eczema after trials of an oral version of the drug reduced patients’ symptoms by 35% within a month. University of Manchester researchers in ...

Amgen AMGN announced positive results from two clinical studies, IGNITE and SHUTTLE, which are part of the phase III ROCKET program that is evaluating the investigational anti-OX40 therapy ...

Amgen AMGN announced positive results from two clinical studies, IGNITE and SHUTTLE, which are part of the phase III ROCKET ...

A monoclonal antibody that targets interleukin (IL)-31 receptor alpha, nemolizumab is specifically indicated for individuals 12 years and older with eczema ... with the drug, and the warnings ...

Lilly hopes that "patients see themselves reflected in the commercial," says Ashley Diaz-Granados, SVP of U.S. immunology ...

While the IGNITE study evaluated rocatinlimab as monotherapy for 24 weeks, the SHUTTLE study evaluated the drug in combination with topical corticosteroids (TCS) and/or topical calcineurin ...

WESTLAKE VILLAGE, Calif. - The U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for ZORYVE (roflumilast) cream 0.05% and has set a Prescription Drug User ...

NIH researchers define diagnostic criteria for topical steroid withdrawal (TSW), distinguishing it from eczema.

Raw Sugar’s new line of shampoo/conditioner directly addresses eczema issues. The post RawSugar’s new shampoo and conditioner aims to soothe your eczema issues appeared first on The Manual.